GHRP-2

Other names in the library: pralmorelin. The cited evidence and any approval concern the studied or labeled preparation. Oral, nasal, cosmetic and research-market versions do not inherit product approval or proven efficacy. Listed sizes: no listed milligram sizes in the vendor file. A seller title is a listing. It does not prove the vial matches a paper.

Growth-hormone-releasing peptide.

We mark the cited papers as C for Limited human safety data; no general wellness benefit established here. and No general wellness indication established.. Limited or preclinical evidence; the grade is not a safety rating. Risks on the record: FDA identifies potential immunogenicity from aggregation and peptide impurities in injectable and nasal preparations. Reports include increased insulin requirements, infection, pancreatitis and deaths in critically ill study participants; causation has not been established.

We mark the cited papers as C. That is our label for how strong those papers are. It does not say the compound works.

The catalog does not record a single hour value. No verified formulation-specific human estimate in this source set; no guessed value is supplied.

Half-life on file: no single hour value. No verified formulation-specific human estimate in this source set; no guessed value is supplied. Follow the label on the vial you hold. This page does not set a throw-away date after you add water.